5 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management

1. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Halbower’s Stake Value: $906.27 million
Percentage of Matthew Halbower’s 13F Portfolio: 7.47%

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is an American pharmaceutical company that focuses on patients affected by rare diseases. The Boston-based company is ranked 1st on the list of the 10 best healthcare stocks to buy according to Matthew Halbower’s Pentwater Capital Management.

Matthew Halbower’s Pentwater Capital Management currently owns 4.9 million shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), amounting to $906.27 million in worth and accounting for 7.47% of the fund’s portfolio. In the second quarter of 2021, Pentwater Capital Management increased its activity in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) by 16%.

Due to its acquisition by AstraZeneca PLC (NASDAQ:AZN) on June 6, Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) began working on immunoregulatory compounds for rare diseases, especially conditions involving immune systems.

As of Q2 2021, 69 hedge funds have positions in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), worth over $10 billion. Out of the hedge funds being tracked by Insider Monkey, California-based investment firm Farallon Capital  is a leading shareholder in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) with over 7.7 million shares worth more than $1.4 billion.

ClearBridge Investments, an investment management firm, in its Q1 2021 investor letter, mentioned Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Here is what the fund said:

“We also sold biotechnology holding Alexion Pharmaceuticals ahead of its acquisition by AstraZeneca but expect to redouble our efforts in health care through the rest of the year. We see good growth potential in the sector and after full due diligence, have been busy populating our wish list with new names we would like to own.”

You can also take a look at 10 Best Dividend Aristocrats to Buy According to Hedge Funds and 10 Best Dividend Stocks to Buy According to John Khoury’s Long Pond Capital.

Follow Insider Monkey on Twitter